ISPOR - PRO26 Cost of illness of Sickle Cell Disease in the US, Payer's Perspective: (CRESCENT).

PRO26 Cost of illness of Sickle Cell Disease in the US, Payer's Perspective: (CRESCENT).

Abstract

Authors

D. S.

Full Text Cite This Article

Back to Volume 24, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now